INTRODUCTION
seizures are themost distinctive manifestation of
neurologic dysfunction in the newborn infant.
the decreased seizure threshold in the newborn is
because of the over development of the excitatory
systems compared to the inhibitory systems.
3.
Neonatal Seizures: ASignal of
Neurological Disease
• Most distinctive indicator of neurological problem in
newborn period
• Common problem in the neonatal ICU that evokes
urgent reaction
• Therefore, it is critical to
– RECOGINZE neonatal seizures
– DETERMINE ETIOLOGY
– TREAT
4.
INCIDENCE
3 / 1000full term infants
60 / 1000 preterm infants
seizures are more common in the newborn period
than at any other time in life
5.
Pathogenesis OF NEONATALSEIZURES
• Developmental brain abnormalities
– Cerebral malformation and dysgenesis and chromosomal
disorders.
• Anoxic-Ischaemic Encephalopathy
– Resulting from prenatal, intrapartum and postnatal factors
• Other causes explained
– The impairment of potassium dependent repolarisation is likely to
cause this age specific epileptic syndrome.
– Receptors families of Excitatory Amino-Acids (EAA) are over
expressed at the stage of brain ontogenesis.
CORRELATION OF TIMEOF ONSET OF
SEIZURES AND AETIOLOGY
Most Frequent Time Aetiology of Seizures
< 48 Hrs. Hypoxic-ischaemic encephalopathy
Intra cranial haemorrhage
Hypoglycemia, Hypoelectrolytemia
Congenital Viral infections
Drug induced
Pyridoxine dependency
Non-ketotic Hyperglycemia
Urea cycle disorder
48-72 Hrs. Cerebral dysgenesis, Early sepsis, Urea cycle
disorder
7 days Organic acidemias, Amino acidopathies,
Bacterial meningitis, BFNC and BINS
8.
Types of NeonatalSeizures
1) SUBTLE SEIZURES
• Eyes : sudden Sustained eye Opening with visual fixation, Ocular
Movements, Blinking, Tonic eye Deviation
• Oral : Chewing, Sucking, lip smacking movements
associated with drooling
• Apnea : Full Term ? Premature
• Motor : Boxing, Hooking, Rotary Pedalling, Stepping movements of
the Extremities
• Autonomic : change in skin colour, Elevated Blood Pressure &
Heart Rate In Premature Infants
9.
CLINICAL SEIZURES -Contd..
2) Clonic Seizures stereotypic and repetitive biphasic movements with fast
contractions and slower relaxation phase
• Focal : Involve face upper + /- lower extremities on one side
“axial structures (neck / trunk)
: Usually associated with neuropathology
(i.e. Cerebral infarction and intra cerebral
haemorrhage)
• Multi focal : Involve several body parts and often migrate in a
non-jacksonian (random) manner may also involve the face.
: Consider the neonatal equivalent of
generalized tonic – clonic seizures.
10.
CLINICAL SEIZURES -Contd..
3) Tonic Seizures
• Focal : Sustained posturing of a limb or asymmetric
posturing of the trunk and / or neck
• Generalised: Decerebrate posturing
Decorticate posturing
Usually associated with apnoea
and upward gaze of eyes
Most common in preemies and usually indicates
structural brain damage and IVH
infants are lethargic and obtunded in between
seizures.
11.
4) Myoclonic seizuresCharacterised brief repeated extension and flexion movements
and non rhythmic character. irregular and erratic
• Multifocal :Asynchronous twitching of several parts of body.
• Generalized :Bilateral jerks of upper and some times lower limbs
associated with diffuse and serious brain damage
associated with poor long term outcome.
12.
NORMAL NEONATAL MOTORACTIVITY
COMMONLY MISTAKEN FOR SEIZURES
AWAKE or DROWSY
• Roving eye movements
• Nystagmoid jerks
• Unsustained Sucking, Puckering
SLEEP
• Fragmentary myoclonic jerks
• Isolate, generalized myoclonic jerks on arousal
13.
CLINICAL CHARACTERISTICS WHICHDISTINGUISH
JITTERINESS FROM SEIZURES
CLINICAL FEATURES JITTERINESS SEIZURES
Stimulus – Sensitive
Movements
+ 0
Movements Cease with
Restraint
+ 0
Associated Abnormal Eye
Movements
0 +
Quality of Movement Tremor Clonic Jerking
heart rate normal or bradycardia tachycardia
14.
INVESTIGATIONS
- Complete Hemogram
-Blood : Sugar, Calcium, Magnesium, Na+
, K+
& HCO3 Elevated Ammonia,
Lactate Levels, Culture & Sensitivity
- CSF analysis: Biochemical & C/s.
- EEG :Plays an important role in dianosis
- neurosonogram, CT and MRI of brain
15.
MANAGEMENT OF NEONATALSEIZURES DURING
ACUTE PHASE
GENERAL MEASURES :
optimise: Ventilation, Circulation, Electrolytes,Acid-Base
Balance
exclusion or treatment of rapidly correctable conditions
establishing the diagnosis of seizures by the clinical or EEG
criteria
specific therapies for treatable conditions like meningitis should
be started but should not delay the start if anticonvulsant
therapy.
16.
MANAGEMENT – Contd..
step1 stabilisation of vital functions
step2: correct transient metabolic disturbance
HYPOGLYCEMIA(RBS<70mg/dl) I.V. 10% DEXTROSE
2ml/kg followed by continuous infusion at 8mg/kg/min
HYPOCALCIMIA 5%calcium gluconate IV at 4ml/kg
HYPOMAGNESEMIA: 50% MGSO4 IM at 0.2ml/kg
17.
step 2 Ifthe Convulsions Persist
↓
Inj. Phenobarbitone 20mg/kg by IV
Given over to 10 mints.
↓
Wait for 30 Mts. if the convulsion
Still Persists
↓
Inj. Phenobarbitone 10mg/kg is given
As IInd Dose.
MANAGEMENT – Contd..
18.
MANAGEMENT – Contd..
Ifthere is further convulsion repeat inj. Phenobarbitone 10mg/kg by I.V.
as third Dose (Cumulative dose of 40 mg/kg) consider omission of
this additional phenobarbitol if the infant is severely Asphyxiated.
+
Administer Inj. Phenytoin sodium concomitantly 15-20 Mg/kg diluted in
Normal Saline (1mg/kg/mt) followed by Maintenance Dose of Inj.
Phenytoin & Phenobarbitone Alternatively
↓
Even then if the convulsions persists inj. Lorazepam 0.05 to 0.1
mg/kg/by I.V. is Administered.
(Contd..)
19.
MANAGEMENT – Contd..
(or)
•Inj. Clonzepam Loading dose of 0.25 mg/kg
followed by 0.01 to 0.03 mg/kg/orally given
(or)
• Inj. Midazolam 0.02 to 0.1 mg/kg - I.V. can be given
• DIAZEPAM : Not safe in neonates as it interferes
with vital functions its sedative effect half life
exceeds 24 hours
20.
DIAGNOSIS & MANAGEMENTOF PDE
• Failure of conventional AEDs
• Pyridoxine 50-100 mg iv
– Caution: May cause severe hypotonia, bradycardia,
apnea
• Treat with daily B6, 200 mg/ day
• B6 withdrawal challenge to confirm dx
– Seizure recur in 7 days to 3 weeks
– Restart B6
21.
DURATION OF ANTICONVULSANTTHERAPY
GUIDELINES
NEONATAL PERIOD
- If neonatal Neurologic examination becomes normal, discontinue
therapy.
- If Neonatal Neurologic examination is persistently abnormal,
consider etiology & obtain EEG.
- In most such cases.
- Continue Phenobarbital
- Discontinue phenytoin
- Re-evaluate in 1 month.
1 Month After Discharge
- If neurologic examination has become normal, discontinue
Phenobarbital
– If neurologic examination is persistently abnormal, obtain EEG.
– If no seizure activity on EEG, discontinue Phenobarbital
22.
EPILEPSY AFTER NEONATAL
SEIZURES
•Overall, 15 – 30% develop seizures later in life
• Again, depends on the cause of neonatal seizures
– Hypoxic – ischemic brain injury 30%
– Cortical dysgenesis 100%
– Hypocalcemia, late 0%
• Other factors include neurologic examination and
neonatal EEG
PROGNOSIS OF NEONATALSEIZURES IN
RELATION TO ETIOLOGY
Etiology Normal Development (%)
Hypoxic Ischemic
Encephalopathy
16-50
Hemorrhage
a) Intraventricular
b) Sub Arachnoid
0-10
85-90
Bacterial Meningitis 25-65
Development Defect 0-5
Hypocalcemia
Early Onset
Late Onset
42-50
91-100
Hypoglycemia 25-50
Unknown 50-62
25.
CONCLUSION
• Neonates withseizures require unique Diagnostic &
Perspective considerations compared with Older Infants
and Children. Neurophysiologic evaluation preferably with
EEG / Video polygraphic monitoring is required for accurate
Detection & Classification
• Fetal (or) Neonatal Disease states may contribute to
seizure Occurrence in later years. Hence the main aim
should be to control the seizure with Anti-convulsants at
any cost apart from treating the underlying cause.